Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Fisher, M.
Right arrow Articles by Campbell, I. W
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Residual cardiovascular risk and practical management of type 2 diabetes

Miles Fisher

Glasgow Royal Infirmary, Glasgow, Scotland, miles.fisher{at}northglasgow.scot.nhs.uk

Ian W Campbell

Victoria Hospital, Kirkcaldy, Fife, Scotland

The evidence base for the optimal management of people with type 2 diabetes has increased dramatically over the last 10 years. Modern management of type 2 diabetes goes beyond glucose lowering and encompasses interventions to impact upon the cluster of cardiovascular risk factors associated with this complex condition. Large, randomised clinical trials have provided evidence for the use of antidiabetic agents, lipid-modulating therapies and antihypertensive agents in order to reduce cardiovascular morbidity and mortality in this high-risk group of patients. Such a multifactorial approach can become an issue for patients in terms of decreased compliance due to increased tablet burden and the complexity of drug regimen. Furthermore, despite optimal care in line with current best practice, people with type 2 diabetes still have a residual risk for cardiovascular disease compared with their counterparts without this condition. Pharmacological agents with additional benefits on cardiovascular risk factors may provide a future strategy for the optimal management of people with type 2 diabetes.

Key Words: case history • evidence-based medicine • risk factor management • multifactorial approach • residual cardiovascular risk.

The British Journal of Diabetes & Vascular Disease, Vol. 6, No. 2 suppl, S17-S23 (2006)
DOI: 10.1177/14746514060060020501
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?